UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by CX Institutional

CX Institutional grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 52.6% during the first quarter, according to its most recent filing with the SEC. The firm owned 16,565 shares of the healthcare conglomerate's stock after acquiring an additional 5,712 shares during the period. CX Institutional's holdings in UnitedHealth Group were worth $8,676,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Capital & Planning LLC raised its holdings in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after buying an additional 79 shares during the last quarter. Brighton Jones LLC boosted its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in UnitedHealth Group in the 4th quarter worth about $27,233,000. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. Finally, Savant Capital LLC boosted its holdings in UnitedHealth Group by 4.3% in the fourth quarter. Savant Capital LLC now owns 21,866 shares of the healthcare conglomerate's stock worth $11,062,000 after purchasing an additional 910 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.8%

Shares of UNH traded up $5.67 during midday trading on Thursday, hitting $316.23. The stock had a trading volume of 7,352,309 shares, compared to its average volume of 7,106,173. The firm has a market cap of $286.86 billion, a PE ratio of 20.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The stock's 50 day moving average is $395.60 and its 200 day moving average is $478.20. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company posted $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.80%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Royal Bank of Canada cut their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Truist Financial reissued a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Oppenheimer decreased their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Finally, Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John H. Noseworthy purchased 300 shares of the stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.